Amneal Pharmaceuticals, Inc. - Class A Common Stock — Liquidità (NASDAQ:AMRX)

Financials

Flusso di cassa derivante dalle attività operative 379 M241.82 M65.1 M345.58 M295.1 M339.99 M 305.84 M Flussi di cassa derivanti dalle attività di investimento -317.55 M-194.18 M-174.31 M-69.19 M-63 M-112.26 M -116.17 M Liquidità derivante dalle attività di finanziamento 131.81 M-138.12 M-106.62 M-212.57 M-211.79 M-31.53 M -51.42 M Liquidità libera 379 M241.82 M65.1 M345.58 M295.1 M254.41 M 221.6 M

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

AMRX

Financials

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Notizie

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

Teva’s CNS Portfolio Is Growing, But Valuation Is Stretched (NYSE:TEVA)

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Do Options Traders Know Something About Amneal Stock We Don't?

Amneal Pharma supera le previsioni EPS nel primo trimestre 2026

Amneal Q1 2026: accordo da 750 mln $ con Kashiv crea leader biosimilari

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High?

Amneal Pharmaceuticals (AMRX) is a Top-Ranked Momentum Stock: Should You Buy?